Green LifeScience Co (114450.KQ) Stock Price

Green LifeScience Co Price

CLOSED
2,295.00
​
Market closed

Over the last 19 years Green LifeScience Co grew revenue by 2.3% annually, reaching 40.34 B KRW. Earnings per share have declined at 14.4% per year over the last 19 years. For Green LifeScience Co, the net margin of 0.3% is up versus -12.4% a few years ago. At today's price the dividend yield works out to roughly 3.27%. The payout ratio is around 141% of earnings.

Green LifeScience Co stock price

Access this data via the Eulerpool API

Green LifeScience Co business model & stock analysis

GREEN LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 68 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ, which is used as crop protection materials; TAZD, which is used as a herbicide intermediate; D003M and T003M, which is used as artificial marble additives, as well as PM04, which is used as a pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.

Frequently asked questions about Green LifeScience Co

Converted at the current exchange rate, the Green LifeScience Co share trades at 1.51 EUR (2,295.00 KRW).

The revenue cannot currently be calculated for Green LifeScience Co.

The profit cannot currently be calculated for Green LifeScience Co.

The P/E ratio cannot be calculated for Green LifeScience Co at the moment.

The P/S cannot be calculated for Green LifeScience Co currently.

The Eulerpool Quality Score for Green LifeScience Co is 2/10.

The ISIN of Green LifeScience Co is KR7114450000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Green LifeScience Co is 114450.KQ. The ticker symbol is used to trade Green LifeScience Co shares on the stock exchange.

Fair ValueTerminal
2,249.10 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
593.23 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website kpxls.com
Country
South Korea
Currency
KRW
Initial public offering
Dec 22, 2009
ISIN
KR7114450000
Cusip
Y4987S100
Market capitalization
44.16 B KRWLarge Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
216.15
P/B Ratio
1.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.29 %
Gross Margin
6.12 %
EBIT Margin
0.51 %
Net Margin
0.27 %
EPS (Earnings Per Share)
7.34 KRW
Net Debt / EBIT
—
Debt/Equity
0.15
Dividend
Dividend yield
0.00 %
Payout Ratio
135.53 %
Dividend growth Ø5Y
—
Dividend payments per year
2
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 5, 2026, 7:23 PM

Green LifeScience Co Peer Group

Green LifeScience Co FIGI

114450:KS · BBG000PV0KG1114450:KQ · BBG000PV0KP1

All fundamentals and in-depth analysis of Green LifeScience Co

Our stock analysis for Green LifeScience Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Green LifeScience Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.